𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: Continued observations

✍ Scribed by Joel M. Kremer; Michael E. Weinblatt; Arthur D. Bankhurst; Ken J. Bulpitt; Roy M. Fleischmann; Christopher G. Jackson; Kelly M. Atkins; Anyang Feng; Daniel J. Burge

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
187 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapy of patients with rheumatoid arth
Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept
✍ Buch, Maya H. ;Bingham, Sarah J. ;Bejarano, Victoria ;Bryer, Domini ;White, Jo ; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Objective The role of alternative tumor necrosis factor (TNF) antagonist therapies in the context of failure of initial TNF antagonist therapy in patients with rheumatoid arthritis (RA) has yet to be clearly defined. The goal of this study was to determine the efficacy of etanercept

Combination therapy with etanercept and
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor Ξ± agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)